More Exclusive Features

Week in Review: Canadian premiers mull recreational marijuana delay, Uruguay begins adult-use sales & Hawaii’s MMJ still on hold

By Matt Lamers, John Schroyer and Bart Schaneman Canada’s provinces consider delaying the launch of the nation’s recreational marijuana industry, adult-use cannabis goes on sale in Uruguay, and Hawaii’s health department stalls the country’s medical MJ market. Here’s a closer look at some notable developments in the marijuana industry over the past week.

Read More

A Canadian marijuana growth strategy: Q&A with Canopy CEO Bruce Linton

By Omar Sacirbey

Canada’s biggest medical marijuana producer, Canopy Growth in Smith Falls, Ontario, serves more than one third of the nation’s MMJ patients and generated 203 million Canadian dollars ($160 million) in revenue last year.

But the company also lost CA$16.7 million.

How? An aggressive expansion plan.

Read More

Canadian cannabis M&As ready to ‘go crazy’: Q&A with Aurora CFO Glen Ibbott

By Omar Sacirbey Glen Ibbott had a successful career as a top executive with U.S. life sciences companies worth hundreds of millions of dollars that listed on the Nasdaq Stock Market. But it wasn’t hard for Canada’s Aurora Cannabis to lure Ibbott north of the border to become the medical marijuana producer’s chief financial officer.

Read More

Hemp-based CBD market continues its enormous growth

By John Schroyer

Just as the marijuana industry has exploded in recent years, so too has a sector that revolves around the plant’s non-psychoactive cousin: hemp.

In particular, demand for hemp-based cannabidiol has skyrocketed, and the resulting need nationwide for more CBD-based health products helped give birth to a new industry that parallels the larger cannabis market.

Read More